Gene therapy Affinia Therapeutics picks up $110m Series B

Affinia Therapeutics, a gene therapy company, has secured $110 million in Series B financing.

Affinia Therapeutics, a gene therapy company, has secured $110 million in Series B financing. EcoR1 Capital and Farallon Capital Management led the round.

Source: Press Release